Researchers at UC Irvine’s Institute for Memory Impairments and Neurological Disorders have received a two-year, $600,000 grant from the National Institute on Aging to develop and study patient-derived stem cell lines.
UCI MIND will host the 24th annual Southern California Alzheimer’s Disease Research Conference on Sept. 20.
From Oct. 1 to 3, the Sue & Bill Gross Stem Cell Research Center joins an international awareness effort, hosting events for local students, the campus community and UCI supporters.
UC Irvine scientists will be part of two research teams garnering CIRM Disease Team Therapy Development Awards, which are designed to accelerate collaborative translational research leading to human clinical trials.
They call it “the baby monitor,” but it’s nothing like the ones sold at Babies “R” Us that alert parents when junior’s crying in his crib. Developed by UC Irvine pediatrics professor Dr. Dan Cooper, the sophisticated wireless device can detect subtle movements in infants that signal increased risk of cerebral palsy, autism and other neurological […]
UCI MIND hosts one of the field’s most influential annual Alzheimer’s disease research conferences featuring speakers and presentations showcasing the latest breakthroughs. Center director Frank LaFerla discusses the 2011 conference and exciting research and treatment efforts for the disease.
Frank LaFerla will study the therapeutic potential of the company’s human neural stem cells.
Researchers with the Institute for Memory Impairments and Neurological Disorders (UCI MIND) have discovered how a novel compound can reduce the accumulation of brain plaques seen in Alzheimer’s disease without the side effects produced by any current drugs used for the chronic neurodegenerative disease.
Frank LaFerla, Hamid Jafarkhani, Diane Campbell and Bert Semler were elected to the world’s largest general scientific society for distinguished contributions to their fields.
Frank LaFerla, David Cribbs, Nabil Dagher, Nick Castello and Rodrigo Medeiros will pedal from Los Angeles to Palm Springs as part of a cross-country effort to make the disease a national priority.